Cracking The North America Facial Aesthetics Market Secret

Growing Adoption of Dermal Fillers in North America

The rising shift of customers towards minimally invasive and non-invasive procedures is expected to drive the growth of the facial aesthetics market. The popularity of dermal fillers has grown rapidly in recent years as they rejuvenate and enhance the aesthetic improvements previously only achievable with surgery, but at a lower cost and with limited-to-no recovery time. The rising aging population coupled with these facial aesthetic procedures comprising smaller incisions, low pain, and lower incidences of post-surgical complications leading to speedy patient recovery are some other factors boosting the market growth of the facial aesthetics market in North America.

Growing adoption of dermal fillers with rising aesthetic surgeries 

The growing concern of people about their appearance is increasing rapidly in North American countries, which leads to an increase in the number of cosmetic surgeries performed annually. For instance, according to the annual plastic surgery procedural statistics, there were 17.5 million surgical and minimally invasive cosmetic procedures performed in the US in 2017, with a 2% increase in the number of procedures over 2016. 

According to a study performed on the American cosmetic industry, the number of non-surgical procedures performed has increased by 461% since 1997. The use of Botox has gone up by 600%, a 205% increase was observed in soft tissue filler use and laser skin resurfacing is now 198% more popular. Surprisingly not all these numbers come from women as 10% of patients were men, leading to a 106% increase in the number of men that opt for aesthetic procedures in the last 20 years.

Facial rejuvenation procedures continue to experience growth, as 2019 has the highest number of botulinum toxin type A injections, with close to 7.7 million injections. The FDA has approved some dermal fillers for the restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus (HIV). 

Hence, the growing acceptance of dermal fillers is driving the growth of the facial aesthetics market in North America. 

Increasing technologically advanced and user-friendly products

Patients are now demanding a wider range of products to treat more and more areas and the average spend per patient in clinics is rising. The companies are innovating technologically advanced products to meet the growing demand. For instance, 

In September 2020, Biotechnology company Revance Therapeutics has introduced a prestige aesthetics portfolio to the U.S. market, starting with its RHA Collection of hyaluronic acid dermal fillers, the first and only FDA-approved dermal fillers for correction of dynamic facial wrinkles and folds as well as an integrated fintech platform called HintMD. Revance also plans to follow those launches with the debut of Daxibotulinumtoxin A for Injection formulated for the treatment of glabellar lines at the end of 2020.

In June 2020, Cynosure launched the Elite iQ platform, the next generation of the Elite+ Aesthetic Workstation that allows for faster treatments with higher max energy compared to previous generation devices. The Elite iQ platform leverages Skintel, the aesthetic industry's only live Melanin Reader™, to offer customized laser hair removal treatments and permanently reduce unwanted hair for all skin types, anywhere on the body including the face, back, chest, arms, underarms, bikini area, and legs.

In June 2020, JÓLI360, the world's first connected skin rejuvenation product, was launched which offers synergetic treatments that bring together unique user-friendly technologies and capabilities. Using a sophisticated skin analyzer, JÓLI360 can accurately measure three skin parameters: Hydration, Elasticity, and Sebum. Leveraging IoT technology, this data is then transferred onto the JÓLI360 touch screen tablet, allowing cosmeticians to provide personalized treatments based on skin conditions and clients' needs.

Gaining Popularity of Non-surgical Nose Job

Non-surgical rhinoplasty also known as the ‘nose filler’ treatment is becoming popular amongst women as well as men. The treatment has been popularized by social media influence, the quick and easy treatments with little downtime involved. It can be used to lift the tip of the nose, smooth out any small bumps or curves on the bridge of the nose and make the nose smaller and more symmetrical. The dermal filler is carefully injected above and below the nose bump to make a hooked nose appear straighter. The tip of the nose can also be lifted by injecting Botox in the nose muscle to continuously pull it down. Many actors and singers have had their appearance tweaked by fillers and it is evident in most cases. In the fast-paced world of today, with social media on the rise and celebrities influencing our actions, people want quick results at an affordable price. Non-surgical nose jobs are giving more people the freedom to look the way they want.

DataM Intelligence - The North American facial aesthetics market is expected to expand at a sluggish CAGR of 11% during the forecast period (2022-2029). In terms of revenue, the facial aesthetics market in North America is estimated to surpass US$  4,096 Mn by 2028, expanding at a CAGR of 11% throughout the forecast period. There is increased competition in the United States, with many players launching several products. For instance, in July 2021, Allergan received US FDA approval for a label expansion of BOTOX to include eight new muscles for the treatment of upper limb spasticity in adults. The U.S. has a growing demand for botulinum toxins and dermal fillers, owing to improving lifestyles and a growing preference for minimally invasive surgeries. The increasing interest in their aesthetic appearance among consumers is driving the growth of the market.